{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:45:10Z","timestamp":1794379510457,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":63,"publisher":"Springer New York","isbn-type":[{"value":"9781441916624","type":"print"},{"value":"9781441916648","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-1-4419-1664-8_1","type":"book-chapter","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T22:30:31Z","timestamp":1280356231000},"page":"1-15","source":"Crossref","is-referenced-by-count":9,"title":["MEN1 Clinical Background"],"prefix":"10.1007","author":[{"given":"Peter","family":"Igaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","volume":"16","author":"P. Wermer","year":"1954","unstructured":"Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954; 16:363\u2013371.","journal-title":"Am J Med"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1023\/A:1026562217102","volume":"1","author":"M.L. Brandi","year":"2000","unstructured":"Brandi ML. Multiple endocrine neoplasia type 1. Rev Endocr Metab Disorders 2000; 1:275\u2013282.","journal-title":"Rev Endocr Metab Disorders"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0889-8529(05)70150-X","volume":"29","author":"R.V. Thakker","year":"2000","unstructured":"Thakker RV. Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 2000; 29:541\u2013567.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","volume":"86","author":"M.L. Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86:5658\u20135671.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00423-001-0268-4","volume":"386","author":"W. Karges","year":"2002","unstructured":"Karges W, Schaaf L, Dralle H et al. Clinical and Molecular diagnosis of multiple endocrine neoplasia type 1. Langenbeck\u2019s Arch Surg 2002; 386:547\u2013552.","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2796.2004.01419.x","volume":"257","author":"S.J. Marx","year":"2005","unstructured":"Marx SJ, Stratakis CA. Multiple endocrine neoplasia. J Intern Med 2005; 257:2\u20135.","journal-title":"J Intern Med"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.med.58.100305.115303","volume":"58","author":"V.T. Lakhani","year":"2007","unstructured":"Lakhani VT, You YN, Wells SA. The multiple endocrine neoplasia syndromes. Annu Rev Med 2007; 58: 253\u2013265.","journal-title":"Annu Rev Med"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.276.5311.404","volume":"276","author":"S.C. Chandrasekharappa","year":"1997","unstructured":"Chandrasekharappa SC, Guru SC, Manickam P et al. Positional cloning of the gene for multiple endocirne neoplasia type 1. Science 1997; 276:404\u2013407.","journal-title":"Science"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrc1610","volume":"5","author":"S.J. Marx","year":"2005","unstructured":"Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nature Rev Cancer 2005; 5:367\u2013375.","journal-title":"Nature Rev Cancer"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2005.02190.x","volume":"62","author":"S. Ellard","year":"2005","unstructured":"Ellard S, Hattersley AT, Brewer CM et al. Detection of an MEN 1 gene mutation depends on clinical features and supports current referral criteria for diagnostic Molecular genetic testing. Clin Endocrinol 2005; 62:169\u2013175.","journal-title":"Clin Endocrinol"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2796.2004.01422.x","volume":"257","author":"J.P. Bilezikian","year":"2005","unstructured":"Bilezikian JP, Brandi ML, Rubin M et al. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Int Med 2005; 257:6\u201317.","journal-title":"J Int Med"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/BF02067335","volume":"16","author":"D. Grama","year":"1992","unstructured":"Grama D, Skogseid B, Wilander E et al. Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World J Surg 1992; 16:611\u2013618.","journal-title":"World J Surg"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0960-7404(03)00038-0","volume":"12","author":"G.M. Doherty","year":"2003","unstructured":"Doherty GM. Multiple endocrine neoplasia type 1: duodenopancreatic tumors. Surg Oncol, 2003; 12:135\u2013143.","journal-title":"Surg Oncol"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1210\/jc.86.11.5282","volume":"86","author":"F. Gibril","year":"2001","unstructured":"Gibril F, Venzon DJ, Ojeaburu JV et al. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressiveand a nonaggressive form. J Clin Endocrinol Metab 2001; 86:5282\u20135293.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR15","first-page":"389","volume":"17","author":"J. Soga","year":"1998","unstructured":"Soga J, Yakuwa Y: Vipoma\/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 1998; 17:389\u2013400.","journal-title":"J Exp Clin Cancer Res"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00000441-200105000-00003","volume":"321","author":"M.A. Chastain","year":"2001","unstructured":"Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001; 321:306\u2013320.","journal-title":"Am J Med Sci"},{"key":"1_CR17","first-page":"13","volume":"18","author":"J. Soga","year":"1999","unstructured":"Soga J, Yakuwa Y: Somatostatinoma\/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 1999; 18:13\u201322.","journal-title":"J Exp Clin Cancer Res"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1046\/j.1365-2796.2003.01164.x","volume":"253","author":"A. Beckers","year":"2003","unstructured":"Beckers A, Berea D, Socin HV et al. The treatment of sporadic versus MEN1-related pituitary adenomas. J Int Med 2003; 253: 599\u2013605.","journal-title":"J Int Med"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00423-006-0124-7","volume":"392","author":"J. Waldmann","year":"2007","unstructured":"Waldmann J, Bartsch DK, Kann PH et al. Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. Langenbecks Arch Surg 2007; 392:437\u2013443.","journal-title":"Langenbecks Arch Surg"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00005792-199701000-00002","volume":"76","author":"B.T. Teh","year":"1997","unstructured":"Teh BT, McArdle J, Chan SP et al. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine (Baltimore) 1997; 76:21\u201329.","journal-title":"Medicine (Baltimore)"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1148\/rg.262055073","volume":"26","author":"A.F. Scarsbrook","year":"2006","unstructured":"Scarsbrook AF, Thakker RV, Wass JAH et al. Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach. Radiographies 2006; 26:433\u2013451.","journal-title":"Radiographies"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-1172-1-38","volume":"1","author":"F. Marini","year":"2006","unstructured":"Marini F, Falchetti A, del Monte F et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Diseases 2006; 1:38\u201346.","journal-title":"Orphanet J Rare Diseases"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1210\/jc.2004-0218","volume":"89","author":"B. Ashgarian","year":"2004","unstructured":"Ashgarian B, Turner MI, Gibril F et al. Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1. J Clin Endocrinol Metab 2004; 89:5328\u20135336.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1158\/1078-0432.CCR-0938-3","volume":"10","author":"B. Asgharian","year":"2004","unstructured":"Asgharian B, Chen YJ, Patronas NJ et al. Meningiomas may be a component tumor of multiple endocrine neoplasia type 1. Clin Cancer Res 2004; 10:869\u2013880.","journal-title":"Clin Cancer Res"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1067\/msy.1998.93107","volume":"124","author":"S.E. Carty","year":"1998","unstructured":"Carty SE, Helm AK, Amico JA et al. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 1998; 124:1106\u20131113.","journal-title":"Surgery"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/(SICI)1098-1004(1998)11:4<264::AID-HUMU2>3.0.CO;2-V","volume":"11","author":"S.E. Olufemi","year":"1998","unstructured":"Olufemi SE, Green JS, Manickam P et al. Common ancestral mutation in the MENI gene is likely responsible for the prolactinoma variant of MENI (MENI Burin) in four kindreds from Newfoundland. Hum Murat 1998; 11:264\u2013269.","journal-title":"Hum Murat"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1210\/jc.2003-031511","volume":"80","author":"W. Hao","year":"2004","unstructured":"Hao W., Skarulis MC, Simonds WF et al. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. J Clin Endocrinol Metab 2004; 80:3776\u20133784.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000076584","volume":"72","author":"M.L. Brandi","year":"2004","unstructured":"Brandi ML, Falchetti A. Genetics of primary hyperparathyroidism. Urol Int 2004; 72 Suppl: 11\u201316.","journal-title":"Urol Int"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/jc.85.1.165","volume":"85","author":"M. Kassem","year":"2000","unstructured":"Kassem M, Kruse TA, Wong FK et al. Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. J Clin Endocrinol Metab 2000; 85:165\u2013167.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/eje.0.1450155","volume":"145","author":"S. Miedlich","year":"2001","unstructured":"Miedlich S, Lohmann T, Schneyer U et al. Familial isolated primary hyperparathyroidism-a multiple endocrine neoplasia type 1 variant? Eur J Endocrinol 2001; 145:155\u2013160.","journal-title":"Eur J Endocrinol"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1046\/j.1365-2265.2003.01765.x","volume":"58","author":"A.A. Pannett","year":"2003","unstructured":"Pannett AA, Kennedy AM, Turner JJ et al. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol 2003; 58:639\u2013646.","journal-title":"Clin Endocrinol"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","volume":"81","author":"W.F. Simonds","year":"2003","unstructured":"Simonds WF, James-Newton LA, Agarwal SK et al. Familial isolated hyperparathyroidism. Clinical and genetic characteristics of 36 kindreds. Medicine 2003; 81:1\u201326.","journal-title":"Medicine"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1530\/eje.1.02022","volume":"153","author":"K.M.A. Dreijerink","year":"2005","unstructured":"Dreijerink KMA, van Beek AP, Lentjes EGWM et al. Acromegalyin a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease. Eur J Endocrinol 2005; 153:741\u2013746.","journal-title":"Eur J Endocrinol"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1210\/jc.2005-2671","volume":"91","author":"A.F. Daly","year":"2006","unstructured":"Daly AF, Jaffrain-Rea ML, Ciccarelli A et al. Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 2006; 91:3316\u20133323.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1365-2265.2000.01032.x","volume":"53","author":"J.R. Burgess","year":"2000","unstructured":"Burgess JR, Nord B, David R et al. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN1). Clin Endocrinol 2000; 53:205\u2013211.","journal-title":"Clin Endocrinol"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1046\/j.1365-2265.2000.00966.x","volume":"52","author":"N. Hai","year":"2000","unstructured":"Hai N, Aoki N, Shimatsu A et al. Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN 1 gene mutations: analysisof 20 Japanese sporadic caseswith MEN1. Clin Endocrinol 2000; 52:509\u2013518.","journal-title":"Clin Endocrinol"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1148\/rg.244035718","volume":"24","author":"J.R. Smith","year":"2004","unstructured":"Smith JR, Oates ME. Radionuclide imaging of the parathyroid glands: patterns, pearls and pitfalls. Radiographies 2004; 24:1101\u20131115.","journal-title":"Radiographies"},{"issue":"Suppl. 1","key":"1_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000080736","volume":"80","author":"R.T. Jensen","year":"2004","unstructured":"Jensen RT. Gastrinomas, advances in diagnosis and management. Neuroendocrinology 2004; (80 Suppl. 1):23\u201327.","journal-title":"Neuroendocrinology"},{"issue":"Suppl. 1","key":"1_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000080735","volume":"80","author":"W.W. Herder","year":"2004","unstructured":"Herder WW. Insulinoma. Neuroendocrinology 2004; (80 Suppl. 1):20\u201322.","journal-title":"Neuroendocrinology"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1210\/jc.78.5.1048","volume":"78","author":"P.C. Kao","year":"1994","unstructured":"Kao PC, Taylor RL, Service FJ. Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma. J Clin Endocrinol Metab 1994; 78:1048\u20131051.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/er.2003-0014","volume":"25","author":"G.A. Kaltsas","year":"2004","unstructured":"Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004; 25:458\u2013511.","journal-title":"Endocr Rev"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1210\/jc.84.8.2712","volume":"84","author":"D. Granberg","year":"1999","unstructured":"Granberg D, Stridsberg M, Seensalu R et al. Plasma chromogranin A in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1999; 84:2712\u20132717.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1210\/jc.82.8.2622","volume":"82","author":"F.R. Nobels","year":"1997","unstructured":"Nobels FR, Kwekkeboom DJ, Coopmans W et al. Chromogranin A as a serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab 1997; 82:2622\u20132628.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/eje.0.1480039","volume":"148","author":"M. Perracchi","year":"2003","unstructured":"Perracchi M, Conte D, Gebbia C et al. Plasma chromogranin A in patients with sporadic gasrro-entcro-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1. Eur J Endocrinol 2003; 148:39\u201343.","journal-title":"Eur J Endocrinol"},{"key":"1_CR45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/172460089901400307","volume":"14","author":"L. Giovanella","year":"1999","unstructured":"Giovanella L, La Rosa S, Ceriani L et al. Chromogranin A as serum marker of neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings. Int J Biol Markers 1999; 14:160\u2013166.","journal-title":"Int J Biol Markers"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.81.4.1623","volume":"81","author":"D. O\u2019Shea","year":"1996","unstructured":"O\u2019Shea D, Rohrer-Theurs AW, Lynn JA et al. Localization of insulinomas by selectiveintraarterial calcium injection. J Clin Endocrinol Metab 1996; 81:1623\u20131627.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1259\/img.14.2.140147","volume":"14","author":"N. Power","year":"2002","unstructured":"Power N, Reznek RH. Imaging pancreatic islet cell tumours. Imaging 2002; 14:147\u2013159.","journal-title":"Imaging"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1210\/jc.86.2.895","volume":"86","author":"G. Kaltsas","year":"2001","unstructured":"Kaltsas G, Korbonits M, Heintz E et al. Comparison of somatostatin analog and metaiodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 2001; 86:895\u2013902.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/eje.0.1510015","volume":"151","author":"G. Kaltsas","year":"2004","unstructured":"Kaltsas G, Rockall A, Papadogias D et al. Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumors. Eur J Endocrinol 2004; 151:15\u201327.","journal-title":"Eur J Endocrinol"},{"key":"1_CR50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1259\/img.14.2.140093","volume":"14","author":"E.J. Evanson","year":"2002","unstructured":"Evanson EJ. Imaging the pituitary gland. Imaging 2002; 14:93\u2013102.","journal-title":"Imaging"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"66","author":"J.W.M. Lenders","year":"2005","unstructured":"Lenders JWM, Eisenhofer G, Mannelli M et al. Phaeochromocytoma. Lancet 2005; 66:665\u2013675.","journal-title":"Lancet"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1530\/eje.0.1490577","volume":"149","author":"E.A.M. Geerdink","year":"2003","unstructured":"Geerdink EAM, van der Luijt RB, Lips CJM. Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? Eur J Endocrinol 2003; 149:577\u2013582.","journal-title":"Eur J Endocrinol"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ymgme.2004.08.013","volume":"83","author":"K. Balogh","year":"2004","unstructured":"Balogh K, Pat\u00f3cs A, Majnik J et al. Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. Mol Genet Metab 2004; 83:74\u201381.","journal-title":"Mol Genet Metab"},{"key":"1_CR54","first-page":"1","volume":"257","author":"T. Carling","year":"2004","unstructured":"Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 2004; 257:1\u201311.","journal-title":"J Intern Med"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/01.cco.0000148567.29850.31","volume":"17","author":"T. Carling","year":"2004","unstructured":"Carling T. Multiple endocrine neoplasia syndrome: genetic basis for clinical management. Curr Opin Oncol 2004; 17:7\u201312.","journal-title":"Curr Opin Oncol"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1210\/jc.2002-021314","volume":"88","author":"F. Gibril","year":"2003","unstructured":"Gibril F, Chen YK, Schrump DS et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2003; 88:1066\u20131081.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1210\/jc.2004-0842","volume":"90","author":"M. Peacock","year":"2005","unstructured":"Peacock M, Bilezikian JP, Klassen PS et al. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 2005; 90:135\u2013141.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"1_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000080743","volume":"80","author":"K. \u00d6berg","year":"2004","unstructured":"\u00d6berg K. Future aspects of somatostatin-receptor-mediated therapy. Neuroendocrinology, 2004; (80 Suppl. 1):57\u201361.","journal-title":"Neuroendocrinology"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1023\/A:1011160913619","volume":"12","author":"C. Waldherr","year":"2001","unstructured":"Waldherr C, Pless M, Maecke HR et al. The clinical value of (90Y-DOTA)-D-Phel-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study. Ann Oncol 2001; 12:941\u2013945.","journal-title":"Ann Oncol"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","volume":"23","author":"D.J. Kwekkeboom","year":"2005","unstructured":"Kwekkeboom DJ, Teunissen JJ, Bakker WH et al. Radiolabeled somatostain analog (177-Lu-DOT-AoTyr3)octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol 2005; 23:2754\u20132762.","journal-title":"J Clin Oncol"},{"key":"1_CR61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0889-8529(18)30114-2","volume":"23","author":"I.E. McCutcheon","year":"1994","unstructured":"McCutcheon IE. Management of individual tumor syndromes: pituitary neoplasia. Endocrinol Metab Clin North Am 1994; 23:37\u201351.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jsbmb.2006.06.011","volume":"101","author":"P. Igaz","year":"2006","unstructured":"Igaz P, Wiener Z, Szab\u00f3 P et al. Functional genomics approaches for the study of sporadic adrenal tumour pathogenesis. Clinical implications. J Steroid Biochem Mol Biol 2006; 101:87\u201396.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1056\/NEJM199903183401107","volume":"340","author":"M.H. Kulke","year":"1999","unstructured":"Kulke MH, Mayer RJ. Carcinoid tumors. N Eng J Med 1999; 340:858\u2013868.","journal-title":"N Eng J Med"}],"container-title":["Advances in Experimental Medicine and Biology","SuperMEN1"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-1664-8_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T20:00:32Z","timestamp":1619812832000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-1664-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9781441916624","9781441916648"],"references-count":63,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-1664-8_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4419-1664-8","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}